Monday, March 15, 2010

MRNA - follow-through

MRNA 480m Trend Model

"It would be nice to catch one of these high flying biotechs before they take off. Are there any clues here?"

1. The act or an instance of following through;
2. Sports The concluding part of a stroke, after a ball or other object has been hit or released.                     
8:31AM MDRNA demonstrates the potential for greater efficacy in cancer with an UsiRNA combination approach (MRNA) 1.04 : Co announced enhanced efficacy for tumor reduction when two UsiRNA were combined within a single formulation. The UsiRNAs targeted two proteins survivin, a protein involved in cell division and inhibition of apoptosis, and PLK1 (Polo-like Kinase 1), a protein involved in cell mitosis and tumor progression. Both UsiRNA were encapsulated in the Company's proprietary DiLA2-based formulation, and delivered directly to the bladder (intravesical) in an orthotopic cancer model. At an equivalent total dose, tumor bioluminescence with a combination approach was significantly lower (~30%), when compared to a single UsiRNA. Additionally, the Company also announced another early collaborative effort with a major international pharmaceutical company bringing the total number of early collaborative efforts to three.


Anonymous said...

now if we could only get a similar report on nnvc

Anonymous said...

This is a good post and chart right here on MRNA.

TA now ,would suggest waiting for the "pullback off the high".... to come back from 1.20
the move from 1.00 to 1.20 .... easy 50% fib to 1.10....wheres the previous break out high spot .... 1.10
thats good enough for me.

Like you said the other day,sometimes you have to take the risk.

If the fundamental story is solid,whats the real risk anyway.

Anonymous said...

Xena Warrior Princess - Ides of March

"What we wish, we readily believe; what we ourselves think, we imagine others think also."

~ Julius Caesar (13 July 100 BC – 15 March 44 BC)

Anonymous said...

With MRNA, I do think it will have a huge run soon. Although for the last number of PRs there has not been much of a movement, it seems to be building critical mass on the upside. with only 40M OS and lots in the pipeline I'm looking for $4.00 plus by summer.